29.04.2024
Б. С. Белов; В. S. Belov; Н. В. Муравьева; Е. Л. Насонов; Е. L. Nasonov
. Significant progress was made during the COVID-19 pandemic due to the dynamic development of vaccine research
19.12.2023
А. Н. Куликов; Н. В. Муравьева; Б. С. Белов; Г. И. Гриднева; Е. С. Аронова
by polymerase chain reaction. In all cases, a mild course of COVID-19 without signs of pneumonia was observed
16.12.2023
Е. С. Аронова; Б. С. Белов; Г. И. Гриднева
Over the past two years since the beginning of the COVID-19 pandemic, many patients have
28.06.2023
А. Н. Куликов; Н. В. Муравьева; Б. С. Белов; С. И. Глухова
17.02.2023
Ш. Ф. Эрдес; Б. С. Белов
over the previous 2.5 years of the COVID-19 pandemic. The issues of clinical and immunological efficacy
16.11.2022
А. Н. КУЛИКОВ; Н. В. МУРАВЬЕВА; Б. С. БЕЛОВ
of developing COVID-19. Vaccination is an effective method of preventing this disease, which may be unsafe
09.09.2022
Б. С. БЕЛОВ; Н. В. МУРАВЬЕВА; А. Н. КУЛИКОВ
The problem of coronavirus disease 2019 (COVID-19) still remains relevant even now, after two
04.05.2022
Б. С. Белов; Т. В. Попкова; Г. М. Тарасова; Н. В. Муравьева
by influenza viruses, hepatitis B, Herpes zoster, human papilloma viruses, COVID-19 and pneumococcus
27.02.2022
Б. С. Белов; А. М. Лила; Е. Л. Насонов
The problem of coronavirus disease 2019 (Coronavirus diseases, COVID-19) two years later still
17.02.2022
А. Н. Куликов; Н. В. Муравьева; Б. С. Белов
Objective: to assess the safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic
